JNJ-67953964

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JNJ-67953964, covering 2023-06-26 to 2025-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants [Phase 1]